JP2021501596A5 - - Google Patents

Download PDF

Info

Publication number
JP2021501596A5
JP2021501596A5 JP2020524540A JP2020524540A JP2021501596A5 JP 2021501596 A5 JP2021501596 A5 JP 2021501596A5 JP 2020524540 A JP2020524540 A JP 2020524540A JP 2020524540 A JP2020524540 A JP 2020524540A JP 2021501596 A5 JP2021501596 A5 JP 2021501596A5
Authority
JP
Japan
Prior art keywords
expansion
lymphocytes
interleukin
apc
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524540A
Other languages
English (en)
Japanese (ja)
Other versions
JP7357613B2 (ja
JP2021501596A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/080343 external-priority patent/WO2019086711A1/en
Publication of JP2021501596A publication Critical patent/JP2021501596A/ja
Publication of JP2021501596A5 publication Critical patent/JP2021501596A5/ja
Application granted granted Critical
Publication of JP7357613B2 publication Critical patent/JP7357613B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524540A 2017-11-06 2018-11-06 リンパ球の拡大方法 Active JP7357613B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762582163P 2017-11-06 2017-11-06
US62/582,163 2017-11-06
PCT/EP2018/080343 WO2019086711A1 (en) 2017-11-06 2018-11-06 Method for expansion of lymphocytes

Publications (3)

Publication Number Publication Date
JP2021501596A JP2021501596A (ja) 2021-01-21
JP2021501596A5 true JP2021501596A5 (cg-RX-API-DMAC7.html) 2021-10-28
JP7357613B2 JP7357613B2 (ja) 2023-10-06

Family

ID=64332272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524540A Active JP7357613B2 (ja) 2017-11-06 2018-11-06 リンパ球の拡大方法

Country Status (7)

Country Link
US (1) US20200338125A1 (cg-RX-API-DMAC7.html)
EP (1) EP3707245A1 (cg-RX-API-DMAC7.html)
JP (1) JP7357613B2 (cg-RX-API-DMAC7.html)
CN (1) CN111801415A (cg-RX-API-DMAC7.html)
AU (1) AU2018361561C1 (cg-RX-API-DMAC7.html)
CA (1) CA3081479A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019086711A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3877055A1 (en) 2018-11-05 2021-09-15 Ludwig Institute for Cancer Research Ltd Humanized and variant tgf-beta1 specific antibodies and methods and uses thereof
CA3118027A1 (en) 2018-11-05 2020-05-14 Ludwig Institute For Cancer Research Ltd. Humanized and variant tgf-.beta.3 specific antibodies and methods and uses thereof
CA3145196A1 (en) * 2019-06-24 2020-12-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. A peptide-based screening method to identify neoantigens for use with tumor infiltrating lymphocytes
JP7337373B2 (ja) * 2019-07-29 2023-09-04 サイアス株式会社 抗原特異的t細胞の製造方法
CA3161510A1 (en) * 2019-12-18 2021-06-24 CBio A/S Improved process for culturing tumor-infiltrating lymphocytes for therapeutic use
WO2021222479A1 (en) 2020-04-28 2021-11-04 Lyell Immunopharma, Inc. Methods for culturing cells
KR20230019460A (ko) * 2020-05-29 2023-02-08 상하이 준셀 테라퓨틱스 컴퍼니 리미티드 종양 침윤 림프구의 종자세포 배지 및 이의 용도
AU2021320556A1 (en) 2020-08-07 2023-03-09 Neogene Therapeutics B.V. Methods to enrich genetically engineered T cells
CA3192356A1 (en) * 2020-08-17 2022-02-24 Northwestern University B-cell based immunotherapy for the treatment of glioblastoma and other cancers
TWI895549B (zh) 2020-11-19 2025-09-01 大陸商蘇州沙礫生物科技有限公司 腫瘤浸潤淋巴細胞的培養方法及其用途
CN112501308B (zh) * 2020-11-30 2025-10-10 中国水产科学研究院珠江水产研究所 一组鳖科动物线粒体全基因组扩增通用引物
US20240043801A1 (en) * 2020-12-24 2024-02-08 Suzhou Grit Biotechnology Co., Ltd. Preparation method for tumor infiltrating lymphocyte and use thereof
CN114686430A (zh) * 2020-12-31 2022-07-01 上海赛比曼生物科技有限公司 一种制备til的方法
AU2022210312A1 (en) * 2021-01-20 2023-08-31 Neogene Therapeutics B.V. Engineered antigen presenting cells
CN115315509B (zh) * 2021-02-08 2024-05-07 苏州沙砾生物科技有限公司 肿瘤浸润淋巴细胞的制备方法及其用途
BR112023022485A2 (pt) * 2021-04-30 2024-01-09 Centre Hospitalier Univ Vaudois Chuv Expansão de linfócitos em um único recipiente
US20240207319A1 (en) 2021-05-06 2024-06-27 Ludwig Institute For Cancer Research Ltd Compositions and methods for immunotherapy
KR20240023426A (ko) * 2021-06-22 2024-02-21 아킬레스 테라퓨틱스 유케이 리미티드 항원-특이적 t 세포를 생산하는 방법
US20240360410A1 (en) * 2021-08-03 2024-10-31 Suzhou Grit Biotechnology Co., Ltd. Modified tumor infiltrating lymphocyte and use thereof
WO2023049733A2 (en) * 2021-09-21 2023-03-30 The University Of Chicago Methods and composition using patient-derived autologous neoantigens for treating cancer
CN115433713B (zh) * 2022-03-03 2023-10-27 中山大学孙逸仙纪念医院深汕中心医院 一种自体肿瘤引流淋巴结淋巴细胞的制备方法及其应用
WO2024261339A1 (en) 2023-06-23 2024-12-26 Tigen Pharma Sa Lymphocyte-stimulatory matrix (lsm) and uses thereof for expansion of lymphocyte populations
WO2025081198A1 (en) * 2023-10-13 2025-04-17 Northwestern University B cell production and expansion
WO2025131119A1 (en) * 2023-12-22 2025-06-26 Everest Medicines (China) Co., Ltd. Cancer vaccines and uses thereof
EP4752217A1 (en) 2024-11-28 2026-06-03 invIOs GmbH Manufacturing method for activated lymphocytes

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905680B2 (en) 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US6534055B1 (en) 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
US7175843B2 (en) 1994-06-03 2007-02-13 Genetics Institute, Llc Methods for selectively stimulating proliferation of T cells
US7067318B2 (en) 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
US6692964B1 (en) 1995-05-04 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy Methods for transfecting T cells
US6291430B1 (en) 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
HK1052372A1 (zh) 2000-02-24 2003-09-11 Xcyte Therapies, Inc. 细胞的同步刺激和富集
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
WO2003015757A1 (en) 2001-08-16 2003-02-27 The Trustees Of The University Of Pennsylvania Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
US8034334B2 (en) 2002-09-06 2011-10-11 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
JP5838021B2 (ja) 2005-04-15 2015-12-24 マクロジェニクス,インコーポレーテッド 共有結合型ダイアボディとその使用
US9963510B2 (en) 2005-04-15 2018-05-08 Macrogenics, Inc. Covalent diabodies and uses thereof
EP1995316A1 (de) 2007-05-25 2008-11-26 Qiagen GmbH Verfahren zur schonenden Zellaufreinigung, Zellgewinnung und Transfektion von Zellen
EP2009095A1 (en) 2007-06-28 2008-12-31 Innovalor AG Method of generating glucose-responsive cells
US8629098B2 (en) 2008-01-15 2014-01-14 Yale University Compositions and methods for adoptive and active immunotherapy
CN101824400B (zh) * 2009-03-05 2012-08-08 中国科学院微生物研究所 一种放大增殖抗原特异性t细胞的方法
US8383099B2 (en) * 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
US9115402B2 (en) * 2010-05-14 2015-08-25 Dana-Farber Cancer Institute, Inc. Compositions and methods of identifying tumor specific neoantigens
US10023657B2 (en) 2010-10-01 2018-07-17 Ludwig Institute For Cancer Research Ltd. Reversible protein multimers, methods for their production and use
BR112014014591A8 (pt) * 2011-12-12 2017-07-04 Baylor College Medicine processo para a expansão in vitro de células t específicas de antígeno, produto de células t autólogas ou alogênicas expandidas, composição farmacêutica, e, método de tratamento de um paciente, e, usos de uma linhagem de células engenheirada, de células dendríticas pulsadas com misturas de antígeno-peptídeo, de t-apcs pulsadas com misturas de antígeno-peptídeo/peptídeo, e de misturas de antígeno-peptídeo com pbmcs
UA123821C2 (uk) * 2014-06-11 2021-06-09 Полібіосепт Гмбх Композиція для експансії лімфоцитів in vitro
SG11201702191YA (en) * 2014-09-17 2017-04-27 Univ Johns Hopkins Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
CN107075479A (zh) * 2014-10-02 2017-08-18 美国卫生和人力服务部 分离对癌症特异性突变具有抗原特异性的t细胞的方法
WO2016145578A1 (en) * 2015-03-13 2016-09-22 Syz Cell Therapy Co. Methods of cancer treatment using activated t cells
WO2017192924A1 (en) * 2016-05-04 2017-11-09 Fred Hutchinson Cancer Research Center Cell-based neoantigen vaccines and uses thereof

Similar Documents

Publication Publication Date Title
JP7391015B2 (ja) P53がん特異的変異に対して抗原特異性を有するt細胞を単離する方法
JP2024001069A (ja) がんを治療するための方法
CN107206024B (zh) 改变cart细胞中的基因表达及其用途
EP3265570B1 (en) Retroviral and lentiviral vectors
AU2023285735A1 (en) Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
JP6942059B2 (ja) クローディン−18.2−特異的免疫受容体およびt細胞エピトープ
JP2022531231A5 (cg-RX-API-DMAC7.html)
CN112955465A (zh) 抗tcr抗体分子及其用途
JP7817937B2 (ja) 腫瘍反応性t細胞のエクスビボ富化および増大のための方法ならびに関連するその組成物
US20230265390A1 (en) Enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof
CN113677352A (zh) T细胞修饰
TW201930591A (zh) 用於與嵌合抗原受體療法併用之免疫增強rna
TWI334442B (en) Process for producing cytotoxic lymphocyte
JP2013014587A (ja) T細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法
JP2017531640A (ja) がん特異的突然変異に対し抗原特異性を有するt細胞受容体を単離する方法
CN101243187B (zh) 淋巴细胞的制备方法
JP2017533707A (ja) T細胞を刺激および拡大する組成物および方法
JP2018511320A (ja) 治療およびエピトープマッピング用T細胞の感作および増殖のためのin vitro人工リンパ節法
JP2024050551A (ja) マウス定常領域を伴うtcrを発現する細胞を選択的に増幅するための方法
WO2019210207A2 (en) Chimeric antigen receptor t regulatory cells for the treatment of atherosclerosis
CA3214450A1 (en) Single vessel expansion of lymphocytes
CN108607094A (zh) 由基因工程化的人造抗原提呈细胞的分泌小体所构建的t细胞疫苗及其制备方法和应用
JP2018510644A (ja) 治療およびエピトープマッピング用T細胞の感作および増殖のためのin vitro人工リンパ節
CN115991790B (zh) 一种增强肿瘤抗原作用的car及其应用
AU2022210312A1 (en) Engineered antigen presenting cells